View Older Stories View More Recent Stories

Dec 1, 2023 04:06PM LianBio (LIAN) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Dec 1, 2023 04:05PM LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Nov 30, 2023 05:09PM Form SC 13D LianBio Filed by: TANG CAPITAL PARTNERS LP
Nov 28, 2023 06:23AM Form SC 13D/A Atea Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
Nov 27, 2023 04:47PM Form SC 13G Kinnate Biopharma Inc. Filed by: TANG CAPITAL PARTNERS LP
Nov 27, 2023 06:30AM Theseus Pharmaceuticals (THRX) Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital and OrbiMed Advisors; Unsolicited Proposal from Concentra Biosciences
Nov 27, 2023 06:30AM Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC
Nov 24, 2023 01:50PM Form SC 13D Theseus Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
Nov 24, 2023 01:50PM Form SC 13G Aclaris Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Nov 14, 2023 09:00PM Form 13F-HR TANG CAPITAL MANAGEMENT For: Sep 30
Nov 1, 2023 04:00PM Form SC 13G LianBio Filed by: TANG CAPITAL PARTNERS LP
Oct 16, 2023 08:05AM Rain Oncology (RAIN) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences for $1.25 Plus CVR
Oct 16, 2023 08:00AM Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Oct 13, 2023 04:58PM Form 4 Rain Oncology Inc. For: Oct 11 Filed by: TANG CAPITAL PARTNERS LP
Oct 13, 2023 04:53PM Form SC 13D/A Rain Oncology Inc. Filed by: TANG CAPITAL PARTNERS LP
Oct 10, 2023 04:00PM Form SC 13G BIONOMICS LIMITED/FI Filed by: TANG CAPITAL PARTNERS LP
Sep 26, 2023 11:06AM Form SC 13G Transcode Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Aug 14, 2023 04:00PM Form 13F-HR TANG CAPITAL MANAGEMENT For: Jun 30
Jul 13, 2023 04:57PM Form SC 13G/A ASLAN Pharmaceuticals Filed by: TANG CAPITAL PARTNERS LP
Jun 6, 2023 04:00PM Form SC 13G AVROBIO, Inc. Filed by: TANG CAPITAL PARTNERS LP
Jun 1, 2023 06:47PM Form 4 Rain Oncology Inc. For: May 30 Filed by: TANG CAPITAL PARTNERS LP
Jun 1, 2023 06:45PM Form 3 Rain Oncology Inc. For: May 30 Filed by: TANG CAPITAL PARTNERS LP
Jun 1, 2023 04:51PM Form SC 13D Rain Oncology Inc. Filed by: TANG CAPITAL PARTNERS LP
May 30, 2023 07:03AM Atea Pharmaceuticals' (AVIR) Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 30, 2023 07:00AM Atea Pharmaceuticals’ Board of Directors Unanimously Rejects Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 23, 2023 04:05PM Atea Pharmaceuticals (AVIR) Confirms $5.75/sh + CVR Acquisition Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 23, 2023 04:05PM Atea Pharmaceuticals Confirms Receipt of Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
May 22, 2023 09:00AM Form SC 13D Atea Pharmaceuticals, Filed by: TANG CAPITAL PARTNERS LP
May 15, 2023 05:12PM Form 4 TCR2 THERAPEUTICS INC. For: May 11 Filed by: TANG CAPITAL PARTNERS LP
May 15, 2023 04:02PM Form 13F-HR TANG CAPITAL MANAGEMENT For: Mar 31
May 10, 2023 07:03PM Form 4 TCR2 THERAPEUTICS INC. For: May 08 Filed by: TANG CAPITAL PARTNERS LP
May 5, 2023 06:53PM Form 4 TCR2 THERAPEUTICS INC. For: May 03 Filed by: TANG CAPITAL PARTNERS LP
May 5, 2023 06:49PM Form 3 TCR2 THERAPEUTICS INC. For: May 03 Filed by: TANG CAPITAL PARTNERS LP
May 5, 2023 04:38PM Form 4 Jounce Therapeutics, For: May 03 Filed by: TANG CAPITAL PARTNERS LP
May 5, 2023 04:37PM Form SC 13G/A TCR2 THERAPEUTICS INC. Filed by: TANG CAPITAL PARTNERS LP
May 5, 2023 04:34PM Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
May 1, 2023 04:01PM Form SC 13G MEI Pharma, Inc. Filed by: TANG CAPITAL PARTNERS LP
May 1, 2023 04:00PM Form SC 13G Genfit S.A. Filed by: TANG CAPITAL PARTNERS LP
Apr 20, 2023 04:15PM Form SC 13G Bolt Biotherapeutics, Filed by: TANG CAPITAL PARTNERS LP
Apr 17, 2023 04:00PM Form SC 13G InflaRx N.V. Filed by: TANG CAPITAL PARTNERS LP
Apr 7, 2023 04:00PM Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Mar 31, 2023 04:01PM Form SC 13G Quince Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Mar 28, 2023 04:01PM Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Mar 27, 2023 09:01AM Jounce Therapeutics (JNCE) to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
Mar 27, 2023 09:00AM Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
Mar 17, 2023 04:01PM Form SC 13D/A Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
Mar 17, 2023 04:00PM Form SC 13G Bellerophon Therapeutics Filed by: TANG CAPITAL PARTNERS LP
Mar 15, 2023 07:51AM Jounce Therapeutics (JNCE) Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Mar 14, 2023 09:00PM Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Mar 14, 2023 05:01PM Form SC 13D Jounce Therapeutics, Filed by: TANG CAPITAL PARTNERS LP
View More Recent Stories View Older Stories